VR Logo

Aurobindo Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

42 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Key Facts

Market cap: R 55,552.84 Cr

Revenue (TTM): R 24,931.56 Cr

Earnings (TTM): R 5,447.94 Cr

Cash: R 2,842.17 Cr

Total Debt: R 5,561.97 Cr

Promoters' ownership: 51.94%

Liquidity: High

52 Week range: R 525.50 - 1,023.70

Face value: R1.00

Shares outstanding: 58,59,38,609

10 Years Aggregate:

  • CFO: 15,504.43 Cr
  • EBITDA: 26,293.18 Cr
  • Net Profit: 15,415.22 Cr

Stock Performance

Time Period Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
YTD3.442.266.11
1 month13.32-3.048.99
3 months1.82-0.414.41
1 Year74.9759.5753.44
3 Years15.1112.4818.47
5 Years3.9413.738.21
10 Years25.659.6714.10
As on 16-Apr-2021
Year Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
2020101.1115.7561.45
2019-37.6914.38-3.55
20186.505.87-5.89
20172.7927.910.49
2016-24.061.95-12.88
201555.43-5.0315.06
2014189.9429.8947.43